Amphicome Emodi

Amphicome emodi  Lindl.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Family Bignoniaceae.
Habitat Temperate Himalaya from Kashmir to Kumaon at 600–2700 m.
Folk Kaur (Kashmir).
Action Plant—febrifuge; used as a substitute for Swertia chirayita.
Taxonomic Cohort Genus Amphicome (1 documented species); Family Bignoniaceae (12 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Amphicome emodi (taxonomically cited with authority Lindl.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Bignoniaceae (primary family classification: Bignoniaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Temperate Himalaya from Kashmir to Kumaon at 600–2700 m.

Across classical and vernacular Indian systems of medicine, Amphicome emodi is recognized under distinct polyglot nomenclature: in regional Indian folk and vernacular ethnobotany as Kaur (Kashmir). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Amphicome emodi are: Plant—febrifuge; used as a substitute for Swertia chirayita. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Amphicome emodi establish the following evidence base: An iridoid glycoside named amphicoside is reported from the plant.

image2

Botanical Reference 1: Amphicome emodi — Wikimedia Commons

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Amphicome emodi stands as a distinct representative of the genus Amphicome. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Bignoniaceae encompasses 12 documented medicinal species (0.66% of the 1,814-species flora). Other representative medicinal members of Bignoniaceae include: Dolichandrone falcate (Mesha-shringi), Heterophragma roxburghii (Waarasa), Jacaranda acutifolia (Nili-gulmohar), Kigelia pinnata (Common Sausage tree), Millingtonia hortensis (Indian Cork tree). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 12 medicinal species of family Bignoniaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Amphicome emodi follow the plant-part modalities specified under its therapeutic action (Plant—febrifuge; used as a substitute for Swertia chirayita), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Amphicome emodi integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top